Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. Clin Genitourin Cancer 2017 Oct;15(5):e897-e901
Date
06/25/2017Pubmed ID
28645484DOI
10.1016/j.clgc.2017.05.018Scopus ID
2-s2.0-85020921698 (requires institutional sign-in at Scopus site) 14 CitationsAuthor List
Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari DAuthors
John Burfeind MD Staff Physician in the Medicine department at Medical College of WisconsinDeepak Kilari MD Associate Professor in the Medicine department at Medical College of Wisconsin
Parag P. Tolat MD Chief, Associate Professor in the Radiology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AdultAntibodies, Monoclonal
Carcinoma, Renal Cell
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Palliative Care
Programmed Cell Death 1 Receptor
Treatment Outcome